Affiliated Treatment Facilities
01. Doctor Overview
Doctor Overview
Dr. Timothy E. Sawyer is a radiation oncologist with over two decades of experience, currently serving at St. Luke’s Mount States Tumor Institute in Boise, Idaho. Previously, Dr. Sawyer served for several years as the medical director at Saint Alphonsus Cancer Care Center. He also served as co-director for lung cancer research at the Mayo Clinic North Central Cancer Treatment Group in Minnesota and taught as an adjunct professor at Johns Hopkins Medical School.
Dr. Sawyer has contributed greatly to cancer research throughout his career, leading and collaborating on a number of clinical trials to develop new treatments and improve standards of care. His research has focused on topics including radiation for unresectable lung cancer and radiation after surgery for lung cancer.
02. Fast Facts
Doctor Fast Facts
Main Specialty: Lung cancer, metastatic cancer, brain cancer, brain tumors, esophageal cancer, head and neck cancer, prostate cancer, colorectal cancer and general radiation oncology.
Other Interests & Specialties: American Board of Radiology Certification in Radiation Oncology, Co-director for lung cancer research at the Mayo Clinic North Central Cancer Treatment Group, member of the American Society of Therapeutic Radiation and Oncology, RSNA Roentgen Resident/Fellow Research Award, American Cancer Society Clinical Oncology Fellowship Award, Morton Fellow
Certifications, Awards & Accolades: American Board of Radiology Certification in Radiation Oncology, Co-director for lung cancer research at the Mayo Clinic North Central Cancer Treatment Group, member of the American Society of Therapeutic Radiation and Oncology, RSNA Roentgen Resident/Fellow Research Award, American Cancer Society Clinical Oncology Fellowship Award, Morton Fellow
Education & Experience:
- Residency in Radiation Oncology from the Mayo Clinic College of Medicine
- Medical Degree from University of Washington School of Medicine
03. Publications
Publications
Postoperative irradiation in non-small cell lung cancer. Seminars in Radiation Oncology. October 2000;10(4):280-8.
Unresectable or medically inoperable non-small cell lung cancer: the use of established clinical prognostic factors in making radiation-related treatment decisions. Seminars in Radiation Oncology. October 2000;10(4):267-73.
Bronchial carcinoid tumors: importance of prognostic factors that influence patterns of recurrence and overall survival. Radiology. July 1998;208(1):181-5. doi: 10.1148/radiology.208.1.9646811
